Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02153749 · ClinicalTrials.gov registry record · NA
Effects of Brief Training on Craving Regulation
A NA study of Nicotine Addiction, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT02153749: Completed NA study of Nicotine Addiction, sponsored by Yale University.
NCT02153749 is a NA study of Nicotine Addiction that has completed, run by Yale University. The registered enrollment target is 92 participants, below the 715-participant average among 10 other Nicotine Addiction trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02153749, a NA study of Nicotine Addiction, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose that brief training in regulation of craving may increase the efficacy of smoking cessation, but that training in cognitive vs. mindfulness-based strategies may operate via different psychological and neural mechanisms.
Primary Outcome
ROC task performance, as change from pre- to post- training in (1) craving (operationalized as self-reported craving on craving trials). (2) strategy-specific regulation (operationalized as scores on regulation trials using the trained strategy: LATER/control trials for CBT-based training, ACCEPT/mindfulness trials for MBT-based training). (3) strategy-non-specific regulation (scores on regulation - using the non-trained strategy: LATER trials for MBT-based training, ACCEPT trials for CBT-based
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Regulation of Craving
- BEHAVIORAL Mindfulness-Based Regulation of Craving
Study Locations (1)
Connecticut
- Clinical & Affective Neuroscience Lab - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-07 |
| Phase | NA |
What the finished NCT02153749 record still lists
NCT02153749 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 715-participant average among 10 other Nicotine Addiction trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Nicotine Addiction appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Regulation of Craving is the first listed.
NCT02153749 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT02153749 about?
NCT02153749 is a clinical study titled "Effects of Brief Training on Craving Regulation". The investigators propose that brief training in regulation of craving may increase the efficacy of smoking cessation, but that training in cognitive vs. mindfulness-based strategies may operate via different psychological and neural mechanisms.
What is the current status of trial NCT02153749?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2015-09. Estimated completion is 2019-07.
What conditions does trial NCT02153749 study?
This clinical trial studies the following conditions: Nicotine Addiction.
What interventions are being tested in trial NCT02153749?
The interventions under investigation include: Cognitive Regulation of Craving (BEHAVIORAL), Mindfulness-Based Regulation of Craving (BEHAVIORAL).
Who is sponsoring clinical trial NCT02153749?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02153749 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02153749's enrollment target sits among peer trials
92 7th of 10 higher than 4 of 10 other Nicotine Addiction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nicotine Addiction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches
RECRUITING · NA
-
CONNECT Cancer Survivors With Tobacco Treatment
RECRUITING · NA
-
Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
RECRUITING · NA
-
Cognitive Training for Nicotine Dependence
COMPLETED · NA
-
Acute and Chronic Nicotine Modulation of Reinforcement Learning
COMPLETED · NA
-
Computer-Facilitated 5A's for Smoking Cessation in Primary Care
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia